About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,041 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,041 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3401-3420 of 4,041 trials

WithdrawnCombination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer PatientsThis is a phase II clinical trial of the combination of carboplatin, eribulin, and Veliparib.NCT03032614 CompletedWomen Surviving Ovarian CancerThe purpose of this study is to help us learn more about how women who have had or now have ovarian cancer are doing 5 years or more from their diagnosis.NCT00596349·New York, New York CompletedOutcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of LifeThis study is being done to see if most patients are willing and able to report how they are feeling after surgery using the internet, and if this information can help doctors and…NCT00870233·New York, New York RecruitingUltrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian CancerThis project is an open, single-center, prospective study aimed at developing high-sensitivity, high-specificity enrichment SERS chips using femtosecond laser processing…NCT06640348·Hefei, Anhui

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

TerminatedStudy of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid TumorsPhase I, first-in-human, open-label, multicenter, dose-escalation and dose expansion study with the aim of exploring safety, tolerability and preliminary antitumor activity of…NCT04182516·Houston, Texas and 9 others

Not yet recruitingPhase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis is an open, multicenter, phase II clinical study enrolling patients with platinum-resistant advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer to…NCT07044349

CompletedTrial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian CarcinomaThe purpose of the study is to compare progression-free survival of conventional paclitaxel and carboplatin vs weekly paclitaxel and carboplatin in patients with newly diagnosed…NCT00226915·Chuo-ku, Tokyo

TerminatedMonoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian CancerRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00006099·New York, New York

RecruitingCirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian CancerThe purpose of this study is to learn about the safety and tolerability of Cirtuvivint in combination with Olaparib in platinum resistant ovarian cancer.NCT06856499·Aurora, Colorado and 1 other

Active not recruitingPembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer PatientsThis pilot clinical trial studies the effect of pembrolizumab and lenvatinib in treating patients with high-grade serous ovarian cancers.NCT05114421·Houston, Texas

CompletedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03662204·Phoenix, Arizona and 118 others

UnknownTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoRATIONALE: Placing a tumor antigen chimeric receptor that has been created in the laboratory into patient autologous or donor-derived T cells may make the body build immune…NCT02580747·Beijing, Beijing Municipality

RecruitingPhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsThe goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated…NCT07424547·Plantation, Florida and 4 others

UnknownExperience in Borderline Ovarian TumorsBorderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers.NCT05791838

UnknownCirculating Tumor DNA Exposure in Peripheral BloodThis is a prospective, multi-center, blinded feasibility study.NCT03517332·Tucson, Arizona and 5 others

UnknownNKG2D CAR-NK & Ovarian CancerThis trial will explore the maximum tolerated dose （MTD）of NKG2D CAR-NK cells in the treatment of platinum-resistant, relapsed epithelial ovarian cancer in a dose-escalation…NCT05776355·Hangzhou, Zhejiang

CompletedBody Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerThis randomized pilot clinical trial studies body warming in improving blood flow and oxygen delivery to tumors in patients with cancer.NCT01896778·Buffalo, New York

RecruitingDiagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis TechniquesThis is a combined prospective and retrospective observational study aiming to validate a highly sensitive and specific blood-based method for the early diagnosis and…NCT07035587·Seoul

RecruitingA Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian CancerThis is a prospective study investigating whether the research on Fasudil Hydrochloride in the treatment of gene-specific ovarian cancer can be applied to predict sensitivity to…NCT06890858·Hangzhou, Zhejiang

TerminatedA Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian CancerThis study is a prospective, single-arm, open-label, single-dose dose finding and extension study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor efficacy…NCT04562298·Shanghai, Shanghai Municipality

PreviousPage 171 of 203Next